Control outcomes and exposures for improving internal validity of nonrandomized studies

Health Services Research

Volumn 50, Issue 5, 2015, Pages 1432-1451

  Dusetzina, Stacie B ^b,c,d   Brookhart, M Alan ^c,d   MacIejewski, Matthew L ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b University of North Carolina   (United States)

^c IL   (United States)

^d UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

control exposures; Control outcomes; falsification tests; nonequivalent exposures; nonequivalent outcomes

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; ATENOLOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIURETIC AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; METOPROLOL; PROTON PUMP INHIBITOR; TAMOXIFEN;

ACUTE HEART INFARCTION; ARTICLE; BARE METAL STENT; CLINICAL STUDY; COMMUNITY ACQUIRED PNEUMONIA; CONCEPTUAL FRAMEWORK; CONTROL EXPOSURE; CONTROL OUTCOME; CRITERION VARIABLE; DELIRIUM; DRUG ELUTING STENT; ELECTIVE SURGERY; HUMAN; ILEUS; INFLUENZA VACCINATION; INFORMATION PROCESSING; INTERNAL BIAS; INTERNAL VALIDITY; KIDNEY FAILURE; MATHEMATICAL PARAMETERS; MEDICAL RESEARCH; MEDICATION COMPLIANCE; MORTALITY; NOMENCLATURE; OUTCOME ASSESSMENT; PNEUMONIA; POSTOPERATIVE COMPLICATION; PUBLICATION; RESPIRATORY FAILURE; RISK ASSESSMENT; SCIENTIST; SYSTEMATIC REVIEW; WOUND INFECTION; METHODOLOGY; PROCEDURES; REPRODUCIBILITY; STANDARDS;

CLINICAL STUDIES AS TOPIC; HUMANS; REPRODUCIBILITY OF RESULTS; RESEARCH DESIGN;

EID: 84942293717     PISSN: 00179124     EISSN: 14756773     Source Type: Journal    
DOI: 10.1111/1475-6773.12279     Document Type: Article

References (35)

1. Aronow, H. D., E. J. Topol, M. T. Roe, P. L. Houghtaling, K. E. Wolski, A. M. Lincoff, R. A. Harrington, R. M. Califf, E. M. Ohman, N. S. Kleiman, M. Keltai, R. G. Wilcox, A. Vahanian, P. W. Armstrong, and, M. S. Lauer,. 2001. " Effect of Lipid-Lowering Therapy on Early Mortality after Acute Coronary Syndromes: An Observational Study." Lancet 357 (9262): 1063-8.
2. Basker, E., 2005. " Job Creation or Destruction? Labor Market Effects of Wal-Mart Expansion." Review of Economics and Statistics 87 (1): 174-83.
3. Benson, K., and, A. J. Hartz,. 2000. " A Comparison of Observational Studies and Randomized, Controlled Trials." New England Journal of Medicine 342 (25): 1878-86.
4. Berger, M. L., N. Dreyer, F. Anderson, A. Towse, A. Sedrakyan, and, S. L. Normand,. 2012. " Prospective Observational Studies to Assess Comparative Effectiveness: The ISPOR Good Research Practices Task Force Report." Value Health 15 (2): 217-30.
5. Berger, M. L., B. C. Martin, D. Husereau, K. Worley, J. D. Allen, W. Yang, N. C. Quon, C. D. Mullins, K. H. Kahler, and, W. Crown,. 2014. " A Questionnaire to Assess the Relevance and Credibility of Observational Studies to Inform Health Care Decision Making: An ISPOR-AMCP-NPC Good Practice Task Force Report." Value Health 17 (2): 143-56.
6. Brookhart, M. A., A. R. Patrick, C. Dormuth, J. Avorn, W. Shrank, S. M. Cadarette, and, D. H. Solomon,. 2007. " Adherence to Lipid-Lowering Therapy and the Use of Preventive Health Services: An Investigation of the Healthy User Effect." American Journal of Epidemiology 166 (3): 348-54.
7. Brookhart, M. A., A. R. Patrick, W. H. Shrank, and, C. R. Dormuth,. 2010a. " Validating Studies of Adherence through the Use of Control Outcomes and Exposures." American Journal of Hypertension 23 (2): 110.
8. Brookhart, M. A., T. Sturmer, R. J. Glynn, J. Rassen, and, S. Schneeweiss,. 2010b. " Confounding Control in Healthcare Database Research: Challenges and Potential Approaches." Medical Care 48 (6 Suppl): S114-20.
9. Concato, J., N. Shah, and, R. I. Horwitz,. 2000. " Randomized, Controlled Trials, Observational Studies, and the Hierarchy of Research Designs." New England Journal of Medicine 342 (25): 1887-92.
10. Dormuth, C. R., A. R. Patrick, W. H. Shrank, J. M. Wright, R. J. Glynn, J. Sutherland, and, M. A. Brookhart,. 2009. " Statin Adherence and Risk of Accidents: A Cautionary Tale." Circulation 119 (15): 2051-7.
11. Dusetzina, S. B., G. C. Alexander, R. A. Freedman, H. A. Huskamp, and, N. L. Keating,. 2013. " Trends in Co-Prescribing of Antidepressants and Tamoxifen among Women with Breast Cancer, 2004-2010." Breast Cancer Research and Treatment 137 (1): 285-96.
12. Furlan, A. D., G. Tomlinson, A. A. Jadad, and, C. Bombardier,. 2008. " Methodological Quality and Homogeneity Influenced Agreement between Randomized Trials and Nonrandomized Studies of the Same Intervention for Back Pain." Journal of Clinical Epidemiology 61 (3): 209-31.
13. Hernan, M. A., S. Hernandez-Diaz, M. M. Werler, and, A. A. Mitchell,. 2002. " Causal Knowledge as a Prerequisite for Confounding Evaluation: An Application to Birth Defects Epidemiology." American Journal of Epidemiology 155 (2): 176-84.
14. Hernan, M. A., A. Alonso, R. Logan, F. Grodstein, K. B. Michels, W. C. Willett, J. E. Manson, and, J. M. Robins,. 2008. " Observational Studies Analyzed Like Randomized Experiments: An Application to Postmenopausal Hormone Therapy and Coronary Heart Disease." Epidemiology 19 (6): 766-79.
15. Hill, A. B., 1965. " The Environment and Disease: Association or Causation? " Proceedings of the Royal Society of Medicine 58: 295-300.
16. Holmlund, H., S. McNally, and, M. Viarengo,. 2010. " Does Money Matter for Schools? " Economics of Education Review 29 (6): 1154-64.
17. Ioannidis, J. P., 2005. " Contradicted and Initially Stronger Effects in Highly Cited Clinical Research." Journal of the American Medical Association 294 (2): 218-28.
18. Ioannidis, J. P., A. B. Haidich, M. Pappa, N. Pantazis, S. I. Kokori, M. G. Tektonidou, D. G. Contopoulos-Ioannidis, and, J. Lau,. 2001. " Comparison of Evidence of Treatment Effects in Randomized and Nonrandomized Studies." Journal of the American Medical Association 286 (7): 821-30.
19. Jackson, L. A., M. L. Jackson, J. C. Nelson, K. M. Neuzil, and, N. S. Weiss,. 2006. " Evidence of Bias in Estimates of Influenza Vaccine Effectiveness in Seniors." International Journal of Epidemiology 35 (2): 337-44.
20. Jena, A. B., E. Sun, and, D. P. Goldman,. 2013. " Confounding in the Association of Proton Pump Inhibitor Use with Risk of Community-Acquired Pneumonia." Journal of General Internal Medicine 28 (2): 223-30.
21. Lipsitch, M., E. Tchetgen Tchetgen, and, T. Cohen,. 2010. " Negative Controls: A Tool for Detecting Confounding and Bias in Observational Studies." Epidemiology 21 (3): 383-8.
22. Maciejewski, M. L., J. F. Farley, J. Parker, and, D. Wansink,. 2010. " Copayment Reductions Generate Greater Medication Adherence in Targeted Patients." Health Affairs (Millwood) 29 (11): 2002-8.
23. Manson, J. E., J. Hsia, K. C. Johnson, J. E. Rossouw, A. R. Assaf, N. L. Lasser, M. Trevisan, H. R. Black, S. R. Heckbert, R. Detrano, O. L. Strickland, N. D. Wong, J. R. Crouse, E. Stein, and, M. Cushman,. 2003. " Estrogen Plus Progestin and the Risk of Coronary Heart Disease." New England Journal of Medicine 349 (6): 523-34.
24. Mauri, L., T. S. Silbaugh, R. E. Wolf, K. Zelevinsky, A. Lovett, Z. Zhou, F. S. Resnic, and, S. L. Normand,. 2008. " Long-Term Clinical Outcomes after Drug-Eluting and Bare-Metal Stenting in Massachusetts." Circulation 118 (18): 1817-27.
25. McClellan, M., B. J. McNeil, and, J. P. Newhouse,. 1994. " Does More Intensive Treatment of Acute Myocardial Infarction in the Elderly Reduce Mortality? Analysis Using Instrumental Variables." Journal of the American Medical Association 272 (11): 859-66.
26. Patrick, A. R., W. H. Shrank, R. J. Glynn, D. H. Solomon, C. R. Dormuth, J. Avorn, S. M. Cadarette, H. Mogun, and, M. A. Brookhart,. 2011. " The Association between Statin Use and Outcomes Potentially Attributable to an Unhealthy Lifestyle in Older Adults." Value Health 14 (4): 513-20.
27. Prasad, V., and, A. B. Jena,. 2013. " Prespecified Falsification end Points: Can They Validate True Observational Associations? " Journal of the American Medical Association 309 (3): 241-2.
28. Rasmussen, J. N., A. Chong, and, D. A. Alter,. 2007. " Relationship between Adherence to Evidence-Based Pharmacotherapy and Long-Term Mortality after Acute Myocardial Infarction." Journal of the American Medical Association 297 (2): 177-86.
29. Ray, W. A., 2003. " Evaluating Medication Effects Outside of Clinical Trials: New-User Designs." American Journal of Epidemiology 158 (9): 915-20.
30. Redelmeier, D., D. Scales, and, A. Kopp,. 2005. " Beta Blockers for Elective Surgery in Elderly Patients: Population Based, Retrospective Cohort Study." British Medical Journal 331 (7522): 932.
31. Robins, J. M., 2001. " Data, Design, and Background Knowledge in Etiologic Inference." Epidemiology 12 (3): 313-20.
32. Rothstein, J., 2010. " Teacher Quality in Educational Production: Tracking, Decay, and Student Achievement." Quarterly Journal of Economics 125 (1): 175-214.
33. Schneeweiss, S., A. R. Patrick, T. Sturmer, M. A. Brookhart, J. Avorn, M. Maclure, K. J. Rothman, and, R. J. Glynn,. 2007. " Increasing Levels of Restriction in Pharmacoepidemiologic Database Studies of Elderly and Comparison with Randomized Trial Results." Medical Care 45 (10 Supl 2): 131-42.
34. Stenestrand, U., and, L. Wallentin,. 2001. " Early Statin Treatment Following Acute Myocardial Infarction and 1-Year Survival." Journal of the American Medical Association 285 (4): 430-6.
35. Zaadstra, B. M., A. M. Chorus, S. van Buuren, H. Kalsbeek, and, J. M. van Noort,. 2008. " Selective Association of Multiple Sclerosis with Infectious Mononucleosis." Multiple Sclerosis 14 (3): 307-13.